| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72a496d0fb758c10d49d24509ee2f9de |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-12 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2292
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01B23-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-1468 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C01B23-00 |
| filingDate |
2015-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d5ac9a286838cd65bf4a53d9f444eb0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80fbea2fc67b6e2bcfc5501578f16480
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24f0a42f7c928148f185d9a61aa62671
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42022c1d666439c824dc15370cec4fd3 |
| publicationDate |
2017-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017061663-A1 |
| titleOfInvention |
Method for preparing ophthalmic preparation containing thymosin beta-4 |
| abstract |
The present invention relates to a method for preparing an ophthalmic preparation containing thymosin beta-4. According to the preparation method of the present invention, since an ophthalmic preparation containing thymosin beta-4 is prepared in the presence of an inert gas, contact between thymosin beta-4 and oxygen is blocked, thereby enabling the activity of thymosin beta-4 to be maintained for a long time without the degeneration thereof caused by oxygen, and thus an ophthalmic preparation product prepared by the preparation method of the present invention can stably maintain the pharmacological activity of thymosin beta-4 for a long time. |
| priorityDate |
2015-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |